DS
WST icon

Dudley & Shanley’s West Pharmaceutical WST Stock Holding History

Dudley & Shanley’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-78,661
Closed -$25.8M – 37
2024
Q4 		$25.8M Sell
78,661
-2,470
-3% -$777K 3.98% 9
2024
Q3 		$24.4M Buy
81,131
+11,085
+16% +$3.39M 3.81% 12
2024
Q2 		$23.1M Buy
70,046
+8,160
+13% +$2.88M 3.97% 11
2024
Q1 		$24.5M Buy
61,886
+830
+1% +$307K 4.13% 12
2023
Q4 		$21.5M Buy
61,056
+8,976
+17% +$3.18M 3.83% 11
2023
Q3 		$19.5M Hold
52,080
– – 3.69% 13
2023
Q2 		$19.9M Buy
52,080
+22,640
+77% +$8.09M 3.6% 13
2023
Q1 		$10.2M Buy
29,440
+25,040
+569% +$7.32M 1.96% 20
2022
Q4 		$1.04M Buy
+4,400
New +$1.04M 0.23% 30

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Dudley & Shanley's WST Position: Q1 2025 in Review

Dudley & Shanley sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 78,661 shares — an estimated $25.8M sold.

Dudley & Shanley first reported a position in WST in Q4 2022 and held it in 9 quarters. The position peaked at $25.8M in Q4 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Dudley & Shanley reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Dudley & Shanley sold 78,661 West Pharmaceutical shares in Q1 2025, an estimated $25.8M.
  • Dudley & Shanley first reported a position in West Pharmaceutical in Q4 2022 and held it in 9 quarters.
  • Dudley & Shanley's West Pharmaceutical position peaked at $25.8M in Q4 2024.
  • 715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Dudley & Shanley's 13F filing for Q1 2025, filed 9 Apr 2025.